KALA vs SNOW · $54.3M cap vs rev $1.55B
Kala Pharmaceuticals Inc (KALA) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported SNOW revenue for 2026-07-31 was $1.55B. Net income was -$191.7M. Revenue was up 11.2% from 2026-04-30 to 2026-07-31. SNOW currently screens at market cap $73.90B.
KALA currently screens at market cap $54.3M. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the KALA and SNOW stock pages for the full models.
Not investment advice.